Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Capitalization 53.04M 38.96M P/E ratio 2022
-575x
P/E ratio 2023 -101x
Enterprise value 53.09M 38.99M EV / Sales 2022
66.3x
EV / Sales 2023 63.5x
Free-Float
30.43%
Yield 2022 *
-
Yield 2023 -
More valuation ratios * Estimated data
Dynamic Chart
Eastwood Bio-Medical Canada Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024 CI
Eastwood Bio-Medical Canada Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 CI
Eastwood Bio-Medical Canada Inc. Reports Earnings Results for the Full Year Ended October 31, 2023 CI
Eastwood Bio-Medical Canada Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 CI
Eastwood Bio-Medical Canada Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023 CI
Eastwood Bio-Medical Canada Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023 CI
Eastwood Bio-Medical Canada Inc. Auditor Raises 'Going Concern' Doubt CI
Eastwood Bio-Medical Canada Inc. Reports Earnings Results for the Full Year Ended October 31, 2022 CI
Eastwood Bio-Medical Canada Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022 CI
Eastwood Bio-Medical Canada Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022 CI
Eastwood Bio-Medical Canada Inc.(TSXV:EBM) dropped from S&P/TSX Venture Composite Index CI
Eastwood Bio-Medical Canada Inc. Reports Earnings Results for the First Quarter Ended January 31, 2022 CI
Eastwood Bio-Medical Canada Inc. Reports Earnings Results for the Full Year Ended October 31, 2021 CI
More news
1 day-3.75%
1 week+35.09%
Current month+35.09%
1 month+55.56%
3 months+28.33%
6 months+2.67%
Current year+40.00%
More quotes
1 week
0.64
Extreme 0.64
0.80
1 month
0.28
Extreme 0.28
0.80
Current year
0.28
Extreme 0.28
0.88
1 year
0.28
Extreme 0.28
1.10
3 years
0.28
Extreme 0.28
2.00
5 years
0.00
Extreme 0
3.00
10 years
0.00
Extreme 0
8.49
More quotes
Director TitleAgeSince
Chief Executive Officer - 20-09-03
Director of Finance/CFO 41 12-04-30
Manager TitleAgeSince
Director of Finance/CFO 41 12-04-30
Director/Board Member 69 13-07-07
Director/Board Member 77 13-07-07
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-3.75%+35.09%+2.67%-42.96%39.08M
-5.99%-3.73%-1.73%+40.28%4.58B
-0.07%-0.73%-31.54%-13.71%3.53B
-1.40%-1.47%+5.00%+2.77%3B
-1.60%-4.26%-19.06%-8.01%2.61B
-2.25%-2.32%-17.02%-26.89%2.22B
-4.82%-8.01%+39.43%+101.77%1.81B
-0.16%-1.60%-18.41%-40.33%1.42B
-0.63%-0.94%-26.28%-32.55%1.35B
-1.50%-1.50%+9.17%-16.46%1.29B
Average -2.22%+0.66%-5.78%-3.61% 2.19B
Weighted average by Cap. -2.42%-3.57%-7.80%+5.65%
See all sector performances
2022 2023
Net sales 1.3M 955K 868K 637K
Net income -150K -110K -547K -401K
Net Debt 22.41K 16.46K 43.52K 31.96K
More financial data * Estimated data
Logo Eastwood Bio-Medical Canada Inc.
Eastwood Bio-Medical Canada Inc. is a Canada-based company, which is engaged in marketing and distributing natural health products in North America. The Company is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients that are presented in tea or capsule forms. The Company's Eleotin products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. Its licensed products which have secured Health Canada product license numbers include Eleotin A 700, Eleotin AL88, Eleotin Cal20, Eleotin V3D, Eleotin G2000, Eleotin H55, and Eleotin Zn330. Additionally, Eleotin Bentley and Eleotin LBM have received Health Canada product license numbers. The Eleotin Bentley is used to promote healthy glucose levels. The Eleotin LBM is recommended for hypertension relief. The Company markets its products in Asia, United States and Canada.
Employees
0
More about the company
Date Price Change Volume
24-09-06 0.7700 $ -3.75% 3,648
24-09-05 0.8000 $ +25.00% 500
24-09-04 0.6400 $ -1.54% 3,170

Delayed Quote Toronto S.E., September 06, 2024 at 03:58 pm EDT

More quotes
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW